Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) came under pressure in the premarket on Tuesday after the company’s Q1 2025 ...

Intraocular inflammation occurred more frequently with 8-mg aflibercept (Eylea) compared with what ... Today that "inflammation after intravitreal injections can sometimes be from endophthalmitis ...

Important Safety Information: EYLEA HD and EYLEA are administered via intravitreal injection. Patients should not use EYLEA HD if they have ocular or periocular infections, active intraocular ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period – halving the number of injections that are ...

If approved, EYLEA HD would be the first and only treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period, reducing the number of injections by half ...

The incidence of mild intraocular inflammation (IOI) in the real world occurs more frequently after intravitreal injection of ...

EYLEA HD was developed to achieve comparable efficacy and safety to EYLEA, but with fewer injections. EYLEA HD is supported by a robust body of research and is currently approved in the U.S. to ...

It is highly similar to the reference product Eylea® (aflibercept ... with or without occlusion may occur following intravitreal injections. Patients and/or caregivers should be instructed ...